Pharmacokinetic modeling of recombinant interleukin-2 in patients with human immunodeficiency virus infection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacokinetic modeling of recombinant interleukin-2 in patients with human immunodeficiency virus infection

Published:1998-11 Issue:5 Volume:64 Page:492-498
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:
Short-container-title:Clin Pharmacol Ther

Author:

Piscitelli Stephen C.,Forrest Alan,Vogel Susan,Chaitt Doreen,Metcalf Julia,Stevens Randy,Baseler Michael,Davey Richard T.,Kovacs Joseph A.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Reference26 articles.

1. Immune-Based Therapies for Treatment of HIV Infection

2. Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome.

3. Controlled Trial of Interleukin-2 Infusions in Patients Infected with the Human Immunodeficiency Virus

4. Subcutaneous Administration of Interleukin‐2 in Human Immunodeficiency Virus Type 1—Infected Persons

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity from a Phase I Study of Simlukafusp Alfa (FAP-IL2v) in Advanced/Metastatic Solid Tumors;Clinical Cancer Research;2024-04-17

2. Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cells;Journal of Autoimmunity;2015-01

3. Utility ofIn VitroMethods in Drug-Drug Interaction Assessment and Prediction for Therapeutic Biologics;Pharmaceutical Sciences Encyclopedia;2013-06-19

4. Interleukin 15 Provides Relief to CTLs from Regulatory T Cell–Mediated Inhibition: Implications for Adoptive T Cell–Based Therapies for Lymphoma;Clinical Cancer Research;2012-11-13

5. Assessing the Hepatic Disposition and Toxicity of Xenobiotics Using Primary Hepatocytes;Encyclopedia of Drug Metabolism and Interactions;2012-10-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3